Skip to main content

and
  1. No Access

    Article

    Chagas Disease Epidemiology in Central America: an Update

    Chagas disease is endemic to all seven Central American countries, where 12% of the population lives in areas where the disease is a risk. While neglect is a pervasive characteristic of Chagas disease in gener...

    Jennifer K. Peterson, Kota Yoshioka, Ken Hashimoto in Current Tropical Medicine Reports (2019)

  2. No Access

    Article

    Chagas Disease in Central America: Recent Findings and Current Challenges in Vector Ecology and Control

    In Central America, most new human Trypanosoma cruzi infections (Chagas disease) are vector-borne, primarily by native vector species. Given the importance of vector control in reducing Chagas disease incidence, ...

    Jennifer K. Peterson, Ken Hashimoto, Kota Yoshioka in Current Tropical Medicine Reports (2019)

  3. No Access

    Article

    Healthcare Disparities in Outcomes of a Metropolitan Congenital Heart Surgery Center: The Effect of Clinical and Socioeconomic Factors

    The purpose of this study is to identify the impact of demographic, socioeconomic, and clinical factors on congenital heart surgery outcomes.

    Jennifer K. Peterson, Kirsti G. Catton in Journal of Racial and Ethnic Health Dispar… (2018)

  4. No Access

    Article

    Enhanced antitumor activity of irofulven in combination with irinotecan in pediatric solid tumor xenograft models

    Irofulven, a novel chemotherapeutic agent with a broad spectrum of activity, is effective against preclinical models of pediatric tumors. The cytotoxic activity of irofulven is augmented when combined with age...

    Michael H. Woo, Jennifer K. Peterson in Cancer Chemotherapy and Pharmacology (2005)

  5. No Access

    Chapter

    Experimental Therapeutics and Preclinical Models

    Jennifer K. Peterson, Peter J. Houghton in Neuroblastoma (2005)